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ATR kinase is a critical upstream regulator of the checkpoint
response to various forms of DNA damage. Previous studies have
shown that ATR is recruited via its binding partner ATR-interacting
protein (ATRIP) to replication protein A (RPA)-covered single-
stranded DNA (RPA-ssDNA) generated at sites of DNA damage
where ATR is then activated by TopBP1 to phosphorylate down-
stream targets including the Chk1 signal transducing kinase. How-
ever, this critical feature of the human ATR-initiated DNA damage
checkpoint signaling has not been demonstrated in a defined
system. Here we describe an in vitro checkpoint system in which
RPA-ssDNA and TopBP1 are essential for phosphorylation of
Chk1 by the purified ATR-ATRIP complex. Checkpoint defective
RPA mutants fail to activate ATR kinase in this system, supporting
the conclusion that this system is a faithful representation of the in
vivo reaction. Interestingly, we find that an alternative form of RPA
(aRPA), which does not support DNA replication, can substitute for
the checkpoint function of RPA in vitro, thus revealing a potential
role for aRPA in the activation of ATR kinase. We also find that
TopBP1 is recruited to RPA-ssDNA in a manner dependent on ATRIP
and that the N terminus of TopBP1 is required for efficient recruit-
ment and activation of ATR kinase.
DNA damage checkpoint ∣ signal transduction ∣ topoisomerase IIβ binding
protein 1
To prevent the potentially catastrophic consequences of DNAdamage, eukaryotic cells activate DNA damage checkpoint
responses which delay cell cycle progression until the damage
is repaired (1, 2). ATR is a member of the phosphoinositide
3-kinase-related protein kinase (PIKK) family and a major reg-
ulator of checkpoint responses to incompletely replicated DNA
and various forms of damaged DNA, including UV-induced DNA
damage (1, 3). ATR forms a complex with ATR-interacting pro-
tein (ATRIP) which is essential for the checkpoint function of
ATR (3). ATRIP directly interacts with replication protein A
(RPA) (4), a heterotrimeric complex consisting of RPA1,
RPA2, and RPA3 subunits, which has high binding affinity for
single-stranded DNA (ssDNA) (5). Previous work with human,
Xenopus, and yeast systems indicates that RPA recruits ATR to
ssDNA through an interaction with ATRIP (4, 6–8). ATR activa-
tion also requires additional checkpoint components, including
the Rad17-RFC complex, the 9-1-1 (Rad9-Hus1-Rad1) check-
point complex, and TopBP1 (2). Interactions between Rad9
and TopBP1 are important for the activation of ATR (9–11). No-
tably, TopBP1 has been shown to be a direct activator of ATR and
strongly stimulates the kinase activity of ATR even in the absence
of other checkpoint components (12, 13). Therefore, the current
model for ATR activation is as follows: ssDNA generated at sites
of DNA damage during repair, transcription, or replication is
bound by RPA, which then recruits ATR through its physical in-
teraction with ATRIP. Independently, the 9-1-1 complex is loaded
by Rad17-RFC at ssDNA containing primer/template junctions,
and the loaded 9-1-1 complex recruits TopBP1 in the proximity
of ATR to activate its kinase function. It has been reported that
mutations in RPA1 that disrupt its interaction with ATRIP also
abrogate ATR activation in yeast, Xenopus, and humans (4, 6,
8). However, the essential role of the ATRIP-RPA interaction
for ATR activation has been questioned by the finding that
ATRphosphorylates Chk1 evenwhen the interaction betweenAT-
RIP and RPA is disrupted by mutations in ATRIP (7). Further-
more, checkpoint defective mutations in RPA1 also disrupt
interactions with other checkpoint proteins, such as Rad9 (14)
and Rad17-RFC (15, 16), indicating that RPA may contribute
at many levels to the activation of ATR.
Therefore, detailed mechanistic studies on the activation of
ATR in a well defined system are necessary to clarify the role
of RPA-coated ssDNA in the checkpoint response. Notably, even
though RPA-coated ssDNA is considered to be the predominant,
if not the sole, signal for activation of the ATR → Chk1 signal
transduction pathway, an in vitro system for ATR-initiated check-
point signaling recapitulating a key feature of the model:
ðRPA-ssDNAÞ þ ðATR-ATRIPÞ þ TopBP1 → Chk1 phosphor-
ylation has not yet been developed. Here, we describe the recon-
stitution of such a system. Moreover, we show that mutations in
RPA1 that abrogate the checkpoint function also disrupt signaling
in our in vitro system, indicating that this system is a reasonable
representation of the signal transduction pathway. In addition, we
demonstrate that an alternative form ofRPA (aRPA), in which the
RPA2 subunit is replaced with RPA4, recruits ATRIP to ssDNA
and stimulates TopBP1-dependent activation of ATR similar to
the canonical RPA. Analysis of the requirements for ATR activa-
tion in this system allowed us to discover that the N terminus of
TopBP1 is required to form a stable checkpoint complex on RPA-
ssDNA required for efficient ATR activation.
Results
In the ATR-mediated DNAdamage checkpoint, the phosphoryla-
tion of Chk1 by ATR in response to ssDNA generated by replica-
tion arrest orDNAdamage processing is considered a key step (3).
Because ssDNA is usually bound to RPA in vivo, it is generally
thought that RPA-ssDNA is the checkpoint signaling structure
(3).Despite the availability of several in vitro systems for analyzing
ATR kinase activity (13, 17–24), this key reaction has not been de-
monstrated with purified proteins. The discovery of TopBP1 as a
potent activator of ATR kinase (12), and the development of a
method to purify ATR from a native source (23) provided the
means to attempt to reconstitute this reaction in a defined system.
Purification of Native ATR-ATRIP. Because of the large size of ATR,
it has been difficult to purify ectopically expressed ATR-ATRIP
using mammalian expression systems. Our efforts to purify ATR-
ATIP by immuno-affinity methods have yielded preparations of
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low activity. Therefore, we decided to carry out our studies with
ATR-ATRIP purified from its native source. We previously de-
scribed a method for the purification of limited amounts of
ATR-ATRIP from HeLa cells (23). In this study, we describe
an improved purification scheme to obtain highly pure ATR-AT-
RIP with a better yield (Fig. 1 and Table S1). We have found that
in testing for ATR-ATRIP activity in cell extracts or partially pur-
ified preparations, some members of the PIKK family, particu-
larly DNA-PK and ATM, are a major source of background
activity. Fortuitously, fractionation of HeLa cell extracts with
35% saturated ammonium sulfate (SAS) precipitated 70%–
80% of the ATR-ATRIP complex while leaving essentially all
DNA-PK and about 90% of ATM in the supernatant (Fig. 1B),
thus providing a good source of ATR-ATRIP free of other PIKKs.
However, as shown in Fig. 1B, at this stage of the purification, the
ATR-ATRIP fraction contains most of the TopBP1 and some of
the RPA in the extract. Because TopBP1 is a key component of
ATR-mediated DNA damage checkpoint signaling, and we
wished to investigate the role of RPA in the checkpoint response,
it was necessary to separate TopBP1 and RPA from ATR-ATRIP.
Hence, ATR-ATRIP was further purified by chromatography
with phosphocellulose and Mono Q resins (Fig. 1C). In the peak
ATR-containing fraction from the Mono Q column, ATR was the
major band by SDS-PAGE/silver stain analysis, and both ATR
and ATRIP were detected by immunoblotting (Fig. 1C, fraction
#3). Functional analysis of the Mono Q fractions revealed a close
correspondence between the ATR-ATRIP peak identified by
immunoblotting and TopBP1-dependent Chk1 phosphorylation
activity (Fig. 1D). Importantly, the final purified fraction is free
of other known checkpoint proteins examined, including TopBP1
and RPA (Fig. 1C), and its kinase activity on Chk1 is completely
dependent on TopBP1 (Fig. 1D, compare lanes 11 and 12).
RPA-ssDNA Dependent Activation of ATR Kinase. In the ATR-
mediated signaling pathway, formation of an RPA-ssDNA com-
plex is considered to be the activator of ATR which phosphory-
lates Chk1. However, this model, which is largely based on in vivo
data and, in part, on data from the Xenopus oocyte extract/sperm
chromatin system, has not been tested critically in vitro (3). In
fact, previous attempts to activate ATR kinase with either ssDNA
or RPA-ssDNA have either failed or yielded marginal stimulation
(8, 23, 25), and activation of ATR-mediated Chk1 phosphoryla-
tion by RPA-ssDNA has not been demonstrated.
With the identification of TopBP1 as a potent activator of ATR
and the availability of ATR-ATRIP isolated from a natural
source, we examined the influence of RPA and DNA in our re-
constituted system. We incubated purified ATR-ATRIP with the
Chk1 substrate in the presence of various combinations of ssDNA,
RPA, and TopBP1 (Fig. 2A). Under our experimental conditions,
even though TopBP1 with or without RPA or ssDNA has a detect-
able stimulatory effect, the combination of RPA-ssDNA and
TopBP1 causes significant phosphorylation of Chk1 byATRabove
that observed with the individual components alone (Fig. 2A and
Fig. S1). Even the highest concentration of RPA addedmarginally
stimulated the TopBP1-dependent ATR kinase activity while
RPA-ssDNA stimulates Chk1 phosphorylation in a dose-depen-
dent manner (Fig. S1). The effect of RPA-ssDNA is observed even
when the ionic strength of the reactionmixture is increased to phy-
siologically relevant concentrations. While at high ionic strength
the overall phospho-Chk1 signal intensity decreases (Fig. 2B,
compare lanes 4, 8, and 12), the signal-to-noise ratio of RPA-
ssDNA vs. RPA or ssDNA alone at 95 mM NaCl becomes appar-
ent after long exposure of the blot (Fig. 2B, bottom inset), indicat-
ing the high specificity for stimulation by RPA-ssDNA. Thus, we
conclude that our system constitutes a reasonably accurate repre-
sentation of the in vivo ATR → Chk1 signaling pathway.
Specificity of RPA-ssDNA Stimulation of ATR Kinase. Having devel-
oped an in vitro assay for phosphorylation of Chk1 by ATR, we
further analyzed in more detail the factors necessary for this
stimulation: RPA, ssDNA, and TopBP1. We first determined
whether the RPA stimulation required human RPA. To this
end, the Saccharomyces cerevisiae ortholog of RPA (scRPA),
Escherichia coli SSB (ecSSB), and the newly discovered human
ortholog of E. coli SSB, the human SSB1 (hSSB1, which has been
implicated in UV-induced DNA damage checkpoint response)
(26) were compared to human RPA (hRPA) in the ATR kinase
assay. All these ssDNA-binding proteins (Fig. S2A) including
Fig. 1. Purification of human ATR-ATRIP from HeLa cells. (A) Purification scheme. (B) Separation of ATR-ATRIP from DNA-PK and ATM by 35% SAS precipita-
tion. ATR was precipitated with 35% SAS, leaving DNA-PK and ATM in the supernatant which then could be precipitated with 55% SAS. The dialyzed fractions
were analyzed by Western blotting with the indicated antibodies. (C) Analysis of purified ATR-ATRIP by Western blotting (top) and silver staining (bottom) of
5%–10% discontinuous SDS-PAGE. (WCE), whole cell extract; L1, 35% SAS fraction loaded onto phosphocellulose column; FT1, flow-through of phosphocel-
lulose column; L2, peak ATR-ATRIP fractions from phosphocellulose were applied to the Mono Q column; FT2, flow-through of Mono Q column; 1–9, Mono Q
fractions. In the bottom, the band corresponding to ATR and the position of ATRIP (which is inefficiently stained by silver) are marked with asterisks in fraction
3. (D) TopBP1-dependent kinase activity of purified fractions. The indicated fractions (1 μL each) were tested for Chk1 phosphorylation in the absence and
presence of TopBP1. The reactions were analyzed by Western blotting for phospho-Chk1 (S345) and Chk1 as indicated.



































scRPA, which is structurally similar to human RPA, failed to
replace human RPA in the kinase assay (Fig. S2B). Thus, these
data indicate that specific interactions between human ATR-
ATRIP and human RPA play an important role in RPA-
ssDNA-mediated ATR activation. This point is further analyzed
in the following section.
Effect of Alternative RPA and of RPA Checkpoint Mutants on Phosphor-
ylation of Chk1 by ATR. To understand the mechanism by which
RPA participates in ATR → Chk1 signaling, we analyzed the ef-
fects of different forms of human RPA, including an alternative
form of RPA (aRPA) in which RPA2 is replaced by RPA4 (27),
and of two RPA mutants which have mutations in the N terminus
of RPA1 subunit: RPA1-t11 (R41E, Y42F) and RPA1-ΔN168
(deletion of the N-terminal 168 amino acids) (28) (Fig. 3A).
Alternative RPA does not support DNA replication although it
has biochemical properties similar to the canonical RPA (29,
30), but it does support nucleotide excision repair (31). To deter-
mine whether aRPA could function in the DNA damage check-
point response, we purified aRPA (Fig. 3B) and examined its
effect on the activation of theATRkinase. Interestingly, aRPA sig-
nificantly stimulates TopBP1-dependent ATR activation in the
presence of ssDNA, and the level of stimulation by aRPA is com-
parable to thatof canonicalRPA(Fig. S3A).Given this observation
and thenotion that recruitment ofATRtoRPA-ssDNAthroughan
ATRIP-RPA interaction is necessary for activation of ATR, we
determined whether aRPA could also recruit ATRIP to ssDNA.
To this end, we analyzed the binding of ATRIP to RPA-ssDNA
and aRPA-ssDNA complexes by a pull-down assay. We found that
ATRIP is efficiently recruited to ssDNA in the presence of either
canonical RPAor aRPA (Fig. S3B), suggesting that this alternative
RPA can substitute for canonical RPA in the ATR-mediated
checkpoint response.
Previous work has shown that two RPAmutants, RPA1-t11 and
RPA1-ΔN168 are defective in checkpoint activation but efficient
for DNA replication in vivo (28). Accordingly, we purified the
RPA mutants to test in our in vitro checkpoint system (Fig. 3B).
In contrast to RPA and aRPA, both RPA1-t11 and RPA1-ΔN168
failed to support Chk1 phosphorylation by ATR (Fig. 3C). DNA
recruitment assays for ATRIP revealed that both RPA mutants
bind to ssDNA with affinities comparable to that of RPA and
aRPA, but fail to recruit ATRIP to the DNA-protein complex
(Fig. 3D). These results indicate that aRPA and RPA, both of
which contain the RPA1 subunit, can equally function in our
checkpoint assay, but RPA with mutations in the RPA1 subunit,
RPA1-t11 or RPA1-ΔN168, does not. Therefore, the N terminus
of RPA1 is essential for the activation of ATR, and impaired
interactions of the RPA mutants with ATRIP cause significant
defects in the ATR-mediated phosphorylation of Chk1. This
result is in agreement with reports that ATRIP interacts with
RPA mainly through the region encompassing the N-terminal
168 amino acids of RPA1 (4, 6, 7, 14).
Role of DNA in ATR → Chk1 Signaling. To further test the model that
RPA-ssDNA is the signal for ATR activation, we investigated the
effects of DNA secondary structure, DNA damage, and DNA
length on the phosphorylation of Chk1 by ATR. In Fig. 4A we
compared the effects of ssDNA and dsDNA on ATR activation
in the absence and presence of RPA. In agreement with our
previous report, both ssDNA and dsDNA stimulated TopBP1-
dependent ATR kinase moderately and at comparable levels
(23). Importantly, while RPA had no significant effect on the
stimulation afforded by dsDNA, it increased the stimulation
conferred by ssDNA nearly 5-fold, indicating that the stimulatory
effect of RPA is highly specific to ssDNA. These results are
consistent with the much higher affinity of RPA to ssDNA relative
to dsDNA, and support the model that RPA-ssDNA is a key
signal for activating ATR kinase.
Fig. 2. TopBP1-dependent ATR activation is stimulated by RPA-ssDNA.
(A) Effect of RPA-ssDNA on ATR kinase. The reactions were carried out with
ATR-ATRTIP, Chk1, TopBP1, RPA, and ϕX174 ssDNA. TheDNA (0.6 nanogram ¼
1.85 pmol nucleotides) was preincubated with RPA (320 fmol) and then ATR-
ATRIP (1 fmol), TopBP1 (50 fmol), and Chk1 (100 fmol) were added and the
mixture was incubated at 30 °C for 20min. Reactions were analyzed by immu-
noblotting for phospho-Chk1 (S345) and Chk1 (top). The levels of Chk1 phos-
phorylation from three experiments were quantified and are plotted
(mean standard error) relative to themaximum (bottom). (B) Effect of ionic
strength on kinase activity. The reactions were conducted as in (A), in reaction
buffers of differing ionic strengths. Short and long exposures of the Western
blot are shown to reveal the stimulatory effects of RPA-ssDNA under differing
ionic strengths. In the quantitative analysis (bottom) the maximum values
obtainedwith RPA-ssDNA at each ionic strengthwere set to 100 and the other
valueswithin each set are expressed relative to those values (averages of three
experiments). Columns 1–8 values were from the short exposure and those in
lane 9–12 were from the long exposure.
Fig. 3. TopBP1-dependent ATR activation is stimulated by canonical and
alternative RPA but not by checkpoint defective RPA mutants. (A) Schematic
of RPA, aRPA, and RPA mutants. (B) Analysis of various forms of RPA by
SDS-PAGE and Coomassie Blue staining. (C) Stimulation of TopBP1-depen-
dent ATR kinase by RPA and aRPA, but not by RPA1-t11 and RPA1-Δ168.
Where indicated, the reactions contained 80, 240, or 720 fmol each RPA com-
plex. Bottom shows quantitative analysis of three experiments. (D) Recruit-
ment of ATRIP to ssDNA by RPA or aRPA, but not by RPA mutants.
Biotinylated 80-mer oligonucleotide (1 pmol)-bound streptavidin beads were
incubated with each RPA complex (4 pmol). The beads were retrieved,
washed, and incubated with ATRIP (5 pmol). The beads were then isolated
and washed, and bound proteins were analyzed by immunoblotting with
the corresponding antibodies. The input lane contains 4 pmol of ATRIP.




















Next, we compared the effect of DNA damage on ATR kinase
activity in the absence and presence of RPA, because of previous
findings that bulky base adducts in dsDNA stimulate TopBP1-
dependent ATR kinase activity (23, 32). At the salt concentration
used in these experiments where no significant stimulation is seen
by dsDNA, the BPDE (benzo[a]pyrene diol epoxide)-damaged
DNA stimulates TopBP1-dependent phosphorylation of Chk1
4–5-fold and this stimulation is not significantly affected by
RPA (Fig. S4). These results are in agreement with the proposal
that recruitment of ATR to DNA by either RPA or directly by
DNA damage enhances its TopBP1-dependent kinase activity
on downstream targets.
The results shown in Fig. 4B reveal a strong effect of DNA
length. At equimolar nucleotide concentrations (and hence
10-fold molar excess of 200 nt-long DNA) the 2,000 nt-long
RPA-DNA was at least 5-fold more efficient than the 200 nt-long
RPA-DNA in stimulating ATR kinase. These findings suggest a
cooperative mechanism in RPA-ssDNA-stimulated and TopBP1-
dependent ATR activation. However, at this point we cannot
propose a physical model for this cooperative reaction. We note,
however, that we previously observed a similar behavior with
stimulation of TopBP1-dependent ATR kinase by damaged
DNA in the absence of RPA (32). Thus, it appears that the
activation of the ATR kinase requires the presence of a critical
number of ATR-ATRIP molecules on the same DNA molecule.
Role of TopBP1 in ATR → Chk1 Signaling. TopBP1 is a multifunc-
tional protein that plays important roles during both DNA repli-
cation and the DNA damage checkpoint response (33). TopBP1
contains 1,522 amino acids with eight BRCT (BRCA1 carboxyl-
terminal) domains located over the entire length of the protein
(33) (Fig. 5A). A region spanning amino acids 978–1,192 (ATR-
Activating Domain (AAD), TopBP1-AAD in Fig. 5A) has been
previously demonstrated to be sufficient to activate ATR kinase
under reaction conditions that were independent of DNA or RPA
(8, 12, 23). However, under stringent reaction conditions (higher
ionic strength), where ATR activation was both TopBP1- and
DNA-dependent, TopBP1-AAD was unable to stimulate ATR ki-
nase due to lack of DNA binding affinity (23, 32). Hence, we
wished to determine if TopBP1-AAD is able to stimulate ATR
activation in the presence of RPA-coated ssDNA. To this end,
we tested TopBP1-AAD and full-length TopBP1 in the presence
of ssDNA or RPA-ssDNA (Fig. 5B). In agreement with our
earlier reports, at the high concentration of DNA, full-length
TopBP1 was capable of stimulating ATR kinase in the absence
of RPA (lane 5) (23, 32). With the combination of RPAþ
ssDNA, full-length TopBP1 stimulated ATR kinase at the low
DNA concentration (lane 6). In contrast, neither ssDNA,
RPA, nor the combination of the two (lane 8–14) was capable
of conferring ATR kinase activation in the presence of
TopBP1-AAD, implying that the AAD of TopBP1 is not sufficient
for RPA-ssDNA-mediated ATR activation. It should be noted
that these concentrations of full-length TopBP1 and TopBP1-
AAD produced similar levels of basal ATR-stimulatory activity
with higher amounts of ATR kinase (23, 32).
We have previously shown that the C terminus of TopBP1, en-
compassing the AAD and the last two BRCT domains (TopBP1-
C), efficiently stimulates the activation of ATR kinase in a man-
ner dependent on the presence of DNA (32). Thus, we examined
this fragment of TopBP1 for ATR activation in the presence of
RPA-ssDNA (Fig. 5C). Interestingly, the results reveal that even
though TopBP1-C can activate ATR at a high DNA concentration
(lane 12), no effect of RPA was observed (lane 13). Using differ-
ent concentrations of TopBP1-C, DNA, and RPA, we confirmed
that TopBP1-C is sufficient for DNA-dependent ATR activation,
but defective for RPA-ssDNA-dependent activation of ATR
(Fig. S5). These results indicate that the N terminus of TopBP1
is required for efficient activation of ATR kinase by RPA-ssDNA.
Recruitment of TopBP1 to ssDNA.Asmentioned above, previous stu-
dies have shown that the chromatin-bound 9-1-1 complex recruits
TopBP1 proximate to ATR, leading to efficient ATR activation
(3). However, it has also been reported that TopBP1 can directly
interact with ATR in a manner dependent on ATRIP (12, 34).
Therefore, we reasoned that under our experimental reaction
conditions, where the 9-1-1 complex is not present, TopBP1 could
be recruited to RPA-ssDNA through interactions with ATRIP.
To address this hypothesis, we first tested whether TopBP1 could
Fig. 4. Effect of DNA secondary structure and DNA length on TopBP1-
dependent activation of ATR. (A) Effect of DNA secondary structure. ATR
and TopBP1 were incubated with 0.3, 1.2, or 5 ng of ϕX174 ssDNA or dsDNA
in the absence or presence of RPA (320 fmol) and the phosphorylation of
Chk1 was detected by immunoblot (top) and quantitative analysis plotted
(bottom). (B) DNA length-dependent ATR activation in the presence of
RPA. The reactions were carried out with various sizes of ssDNA fragments
(0.3, 1.2, or 5 ng) in the presence of RPA (320 fmol). Bottom shows averages
of Chk1 phosphorylation obtained with 5 ng ssDNA.
Fig. 5. The N terminus of TopBP1 is required for efficient ATR activation in
the presence of RPA-ssDNA. (A) Schematic of full-length TopBP1 and its
fragments. The boxes indicate the BRCT regions, and the AAD is indicated.
(B) No stimulatory effect of DNA or RPA-ssDNA on ATR activation in the pre-
sence of the AAD of TopBP1. The reactions were carried out with 50 fmol of
full-length TopBP1 (TopBP1-FL) or 500 fmol of TopBP1-AAD in the presence of
RPA (240 fmol) and different amounts of ϕX174 ssDNA (1 or 10 ng). The levels
of Chk1 phosphorylation were quantified and averages of three experiments
are presented (bottom). (C) Effect of DNA or RPA-ssDNA on ATR activation in
the presence of TopBP1 C terminus. The reactions were performed as in (B),
except with 200 fmol of the C-terminal 1∕3rd of TopBP1 (TopBP1-C) compared
with 50 fmol of full-length TopBP1.



































directly interact with RPA, but observed no significant interac-
tion. Moreover, we found that DNA-bound RPA strongly inhibits
binding of TopBP1 to DNA (Fig. 6A, left), whereas ATRIP bind-
ing to ssDNA is strongly dependent on the presence of RPA un-
der these reaction conditions (right). Next, we examined whether
TopBP1 could recruit ATRIP to DNA and whether ATRIP could
recruit TopBP1 to RPA-ssDNA (Fig. 6B). Although ATRIP does
not bind ssDNA directly (lane 1), we observed that DNA-bound
TopBP1 recruits ATRIP (lane 3). In the presence of RPA-ssDNA,
TopBP1 no longer binds to DNA (lane 5), but importantly we
observed that TopBP1 is recruited to RPA-ssDNA through
interaction with ATRIP (lane 6). Interestingly, we consistently
observed cooperative binding of ATRIP and TopBP1 to RPA-
ssDNA (compare lane 6 with lane 4 for ATRIP binding).
Given the observation that the C terminus of TopBP1 is defec-
tive in RPA-ssDNA activated ATR → Chk1 signaling, we also
tested whether TopBP1-C is recruited by ATRIP to RPA-ssDNA.
While we consistently observed significant recruitment of full-
length TopBP1 by ATRIP to RPA-ssDNA, there is only weak
binding of the C terminus of TopBP1 (Fig. S6). Moreover, we
confirmed that the N terminus of TopBP1 also interacts weakly
with ATRIP and is recruited to RPA-ssDNA, indicating that both
the C- and N-terminal domains of TopBP1 are required to form a
stable checkpoint complex on ssDNA, leading to efficient
ATR → Chk1 signaling (Fig. S6). Collectively, these data indicate
that TopBP1 is recruited to RPA-ssDNA through an interaction
with ATRIP, and this recruitment of TopBP1 might be poten-
tiated by other checkpoint proteins, such as the Rad17-RFC/
9-1-1 complexes (9, 10).
Discussion
Phosphorylation of Chk1 by ATR is possibly the most important
reaction in the DNA damage checkpoint response to genotoxic
stress by UV and UV-mimetic agents. Despite the extensive in
vivo data, it has not been demonstrated that RPA-ssDNA is a
particularly strong signal for activating ATR in a defined system.
In fact, it was found that both in Xenopus and human cell-free
systems the multifunctional replication/repair protein TopBP1
is a potent activator of ATR kinase in the absence of DNA
and any other proteins (12).
However, initial attempts to establish an in vitro system in
which the ATR kinase activity was dependent on RPA-ssDNA
and TopBP1 were not successful. In one study, using the AAD
of TopBP1, no effect of RPA-ssDNA on ATR kinase activity
was observed (8). However, our data show that the AAD of
TopBP1 is unable to confer ssDNA-RPA stimulation. In another
study, ATR kinase reactions containing full-length TopBP1 were
stimulated to comparable levels by ssDNA and dsDNA, but ad-
dition of RPA had only a marginal effect (23). In contrast, unex-
pectedly, it was found that TopBP1-dependent ATR activation
was strongly stimulated by dsDNA damaged by either BPDE
or N-Aco-AAF (N-acetoxy-2-acetylaminofluorene) above and be-
yond the stimulation afforded by dsDNA (23, 32). In yeast, it has
been shown that Dpb11 (TopBP1 ortholog) also directly activates
the Mec1-Ddc2 kinase (ATR-ATRIP ortholog) to phosphorylate
its substrate (25, 35). However, in vitro studies with purified yeast
proteins show that DNA or RPA-ssDNA have no or marginal sti-
mulatory effect on Mec1-Ddc2 kinase activity (25). Finally, in the
current study we have succeeded in establishing an in vitro system
in which phosphorylation of Chk1 by ATR is dependent on both
TopBP1 and RPA-ssDNA.
Webelieve that the systemwehave developed approximates the
in vivo reaction for the following reasons. First, as stated above, it
exhibits a strict requirement forTopBP1andRPA-ssDNA.Second,
it depends on ATRIP-RPA interactions: RPA mutants that fail to
interact with ATRIP and are defective in the checkpoint response
in vivo also fail to support TopBP1-mediated Chk1 phosphoryla-
tion by ATR in our system. However, our in vitro system differs
from the in vivo signaling pathway in some significant aspects as
well. In particular, there appears to be a strict requirement for
the 9-1-1 complex in vivowhich is not present in our in vitro system.
Based on the experience we have gained from establishing an
RPA-ssDNA-dependent system, we expect it should be possible
to develop an in vitro system dependent on the 9-1-1 complex
as well by careful titration of the multiple components of the reac-
tion (ATR-ATRIP, TopBP1, Rad17-RFC/9-1-1 complex, RPA,
Chk1, and DNA) and using appropriate reaction conditions to
achieve higher Chk1 phosphorylation than our current system
in which only about 10% of Chk1 is phosphorylated (24). Indeed,
we have found that the reaction of Chk1 phosphorylation by ATR
is rather sensitive to the reaction conditions, suggesting that with a
better understanding of the conditions that affect the reaction it
should eventually bepossible to reconstitute the checkpoint system
encompassing all of the genetically defined components.
Finally, we wish to comment on the mechanistic significance of
ATR activation under different experimental conditions that do
not encompass the full component of elements necessary for
ATR activation in vivo (Fig. S7). First, the activation by TopBP1
in the absence of DNA or any additional proteins indicates that
TopBP1 might be considered an ATR coactivator which at high
concentrations and in buffers of low ionic strength can bypass
the requirements for DNA or other factors needed for ATR acti-
vation in vivo. Second, under conditions of limiting checkpoint fac-
tors and in low ionic strength buffers, TopBP1 can interact with
DNA and thus form a DNA-TopBP1-(ATR-ATRIP) complex in
which ATR is now active. Under more stringent conditions of
limiting checkpoint factors and high ionic strength, DNA with
bulky adducts, but not undamaged DNA, binds TopBP1 which
Fig. 6. TopBP1 is recruited to RPA-ssDNA in a manner dependent on ATRIP.
(A) Binding of TopBP1 or ATRIP to ssDNA in the absence or presence of RPA.
DNA pull-down assays were performedwith biotinylated 80-mer oligonucleo-
tide (1 pmol)-bound streptavidin beads, RPA (0, 1, 2, 4 pmol), and 1 pmol of
TopBP1 (left) or ATRIP (right). The input lane contains 0.2 pmol of TopBP1 or
ATRIP. (B) Recruitment of ATRIP and TopBP1 to ssDNA and RPA-ssDNA. Bioti-
nylated 80-mer oligonucleotide (1 pmol)-bound streptavidin beadswere incu-
bated with no protein (lane 1–3) or 4 pmol of RPA (lane 4–6). The beads were
retrieved, washed, and incubated with 1 pmol of ATRIP (lane 1 and 4) or
TopBP1 (lane 2 and 5), or both (lane 3 and 6). The bound proteins were sepa-
rated on SDS-PAGE and analyzed by immunoblotting with the corresponding
antibodies. The input lane contains 0.25 pmol of TopBP1 orATRIP. Levels of the
bound proteins from three independent experiments are presented (left).




















in turn binds to and activates ATR.Under still higher stringency of
limiting concentrations of DNA and high ionic strength, which
perhaps most closely approximates the in vivo conditions, the re-
cruitment of ATR-ATRIP to DNA by ATRIP-RPA interactions
predominates. As a consequence, under these conditions, ATR,
in the presence of TopBP1, is activated by theRPA þ ssDNA com-
bination but not by RPA þ dsDNA. It should be noted, however,
that even though the RPA-ATRIP interaction is sufficient to re-
cruit ATR to DNA, this recruitment is not enough to enable
the AAD or C-terminal one-third of TopBP1 (which carries two
BRCT repeats as well as the AAD) to activate ATR kinase. For
activation under these conditions theN terminus of TopBP1 is also
required to form a stable checkpoint complex on RPA-ssDNA.
With respect to the mechanistic aspect of ATR activation, one
more point deserves some consideration: There is a DNA length
dependence for activation, whether ATR is activated by TopBP1
binding to damaged DNA or whether it is recruited by an ATRIP-
RPA interaction to RPA-ssDNA. We suspect that damaged
DNAs or ssDNA shorter than 200 bp (nt) that can only accom-
modate a few TopBP1s or RPAs cannot activate ATR, indicating
that a one-dimensional ATR array of certain length is required to
activate the kinase. At present, other than stating this striking
effect, we cannot offer a mechanistic model. However, we note
that a similar observation was made with ATM in vitro (36, 37)
and moreover that ATM was activated in vivo when it was artifi-
cially recruited to DNA by an array of 256 lac operator-lac repres-
sor interactions (38).
Finally, in this paper we show that aRPA, which is unable to
support DNA replication (29, 30), can function similarly to cano-
nical RPA in the activation of ATR. Moreover, since recent work
has shown that aRPA can function in nucleotide excision repair
and homologous recombination as well (31), it appears that this
form of RPA is specialized for DNA damage response pathways.
Materials and Methods
Antibodies and Preparation of Checkpoint Proteins. See SI Text for details.
Purification of ATR-ATRIP from HeLa Cells. See SI Text for details.
Preparation of DNA Substrates. See SI Text for details.
ATR Kinase Assay. The kinase activity of the ATR-containing fractions was
analyzed using Chk1 as a substrate as described previously (23, 32, 39), with
some modifications. See SI Text for details.
DNA Pull-Down Assays. The binding of checkpoint proteins to DNA was ana-
lyzed by a DNA pull-down assay using the biotin-streptavidin affinity system
as previously described (4), with some modifications. See SI Text for details.
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